MAFFEI, Rossana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.501
AS - Asia 3.627
EU - Europa 3.386
SA - Sud America 430
AF - Africa 87
OC - Oceania 38
Continente sconosciuto - Info sul continente non disponibili 1
Totale 16.070
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.365
GB - Regno Unito 1.034
SG - Singapore 961
CN - Cina 806
HK - Hong Kong 795
IT - Italia 716
VN - Vietnam 413
SE - Svezia 368
DE - Germania 337
BR - Brasile 324
FI - Finlandia 197
BD - Bangladesh 191
RU - Federazione Russa 166
UA - Ucraina 135
FR - Francia 123
TR - Turchia 98
CA - Canada 75
IN - India 72
KR - Corea 61
BG - Bulgaria 51
ID - Indonesia 49
NL - Olanda 42
ES - Italia 40
AU - Australia 38
IE - Irlanda 31
AR - Argentina 29
JP - Giappone 28
ZA - Sudafrica 27
BE - Belgio 26
IQ - Iraq 24
MX - Messico 23
PL - Polonia 23
CL - Cile 20
CZ - Repubblica Ceca 19
AE - Emirati Arabi Uniti 17
PK - Pakistan 17
MA - Marocco 16
PH - Filippine 15
VE - Venezuela 14
EC - Ecuador 13
UZ - Uzbekistan 13
AT - Austria 11
RO - Romania 11
CO - Colombia 10
MY - Malesia 10
CH - Svizzera 9
DK - Danimarca 9
JM - Giamaica 9
JO - Giordania 9
KE - Kenya 9
CR - Costa Rica 8
LT - Lituania 8
PY - Paraguay 7
AZ - Azerbaigian 6
DZ - Algeria 6
EG - Egitto 6
ET - Etiopia 6
SA - Arabia Saudita 6
BZ - Belize 5
DO - Repubblica Dominicana 5
PE - Perù 5
TW - Taiwan 5
BO - Bolivia 4
GR - Grecia 4
SN - Senegal 4
TN - Tunisia 4
AL - Albania 3
BY - Bielorussia 3
CY - Cipro 3
HR - Croazia 3
IL - Israele 3
IR - Iran 3
KZ - Kazakistan 3
PR - Porto Rico 3
QA - Qatar 3
RS - Serbia 3
UY - Uruguay 3
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
MD - Moldavia 2
NG - Nigeria 2
NP - Nepal 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
CI - Costa d'Avorio 1
EE - Estonia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
KW - Kuwait 1
Totale 16.059
Salva come PNG Salva come JPEG
Città #
Ashburn 810
Ann Arbor 792
Hong Kong 791
Fairfield 784
Southend 733
Santa Clara 631
Singapore 575
Woodbridge 469
Houston 417
Chandler 414
Seattle 313
Cambridge 272
San Jose 272
Wilmington 246
Nyköping 243
Jacksonville 215
Hefei 199
Dearborn 196
Los Angeles 161
Chicago 156
Beijing 153
Helsinki 147
London 145
Modena 145
New York 125
Ho Chi Minh City 122
Council Bluffs 114
Hanoi 98
Milan 87
Munich 71
The Dalles 67
Salt Lake City 62
San Diego 61
Seoul 59
Fremont 57
Princeton 55
Lauterbourg 51
Sofia 51
Eugene 46
Izmir 45
Moscow 45
Buffalo 40
Bremen 35
Jakarta 35
Rome 35
Dallas 33
Bologna 32
Tampa 32
Dublin 31
Frankfurt am Main 28
Orem 28
Atlanta 26
Brussels 26
Columbus 25
Shanghai 25
São Paulo 25
Elk Grove Village 24
Phoenix 23
Redwood City 23
Boardman 22
Melbourne 22
Miami 20
Toronto 20
Warsaw 20
Des Moines 19
Tokyo 19
Da Nang 18
Lancaster 18
Montreal 17
Brooklyn 16
Chennai 15
Haiphong 15
Dong Ket 14
Falls Church 14
Brno 13
Denver 13
Tashkent 13
Vancouver 13
Miano 12
Amsterdam 11
Dulles 11
Jinan 11
Naples 11
Reggio Emilia 11
Rio de Janeiro 11
Ankara 10
Baghdad 10
Bari 10
Boston 10
Guangzhou 10
Johannesburg 10
Kent 10
Madrid 10
Ninh Bình 10
Perugia 10
Turku 10
Kilburn 9
Poplar 9
San Francisco 9
Santiago 9
Totale 11.566
Salva come PNG Salva come JPEG
Nome #
Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features. 827
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 592
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 436
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 420
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 389
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 369
Mucorales-specific T cells in patients with hematologic malignancies 363
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 363
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 355
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 354
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 342
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 342
Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis 327
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 326
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 325
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 324
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 322
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 318
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 311
Stereotyped B-cell receptor is an independent risk factor of chronic lymphocytic leukemia transformation to Richter syndrome. 308
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 308
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 307
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 298
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 296
Immunomodulatory effect of ibrutinib: Reducing the barrier against fungal infections 296
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 293
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 291
Comprehensive characterization of IGHV3-21-expressing B-cell chronic lymphocytic leukemia: an Italian multicenter study 291
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 283
Epidemiology and clinical outcomes of latent tuberculosis infection in adults affected with acute leukemia or aplastic anemia: a retrospective single-center study 282
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 280
Strikingly homologous immunoglobulin gene rearrangements and poor outcome inV(H)3-21-using chronic lymphocytic leukemia patients independent of geographic origin and mutational status 276
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 273
BTK Inhibition Impairs the Innate Response Against Fungal Infection in Patients With Chronic Lymphocytic Leukemia 273
The PI3-kinase delta inhibitor idelalisib (GS-1101) targets integrin-mediated adhesion of chronic lymphocytic leukemia (CLL) cell to endothelial and marrow stromal cells 272
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 269
Distribution of different classes of CSF3R mutations and co-mutational pattern in 360 myeloid neoplasia 266
Long-term molecular remission with persistence of BCR-ABL1-specific cytotoxic T cells following imatinib withdrawal in an elderly patient with Philadelphia-positive ALL 262
Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: Results from an Italian multicentre study 255
Vorinostat and bortezomib significantly inhibit WT1 gene expression in MO7-e and P39 cell lines 248
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 248
Circulating endothelial cells in patients with chronic lymphocytic leukemia: clinical-prognostic and biologic significance. 241
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 240
HOXA homeogene cluster interruption and dysregulation of HOAX9 in the blast crisis of Philadelphia chromosome-positive chronic myeloid leukemia. 235
Overexpression of CD49d in trisomy 12 chronic lymphocytic leukemia patients is mediated by IRF4 through induction of IKAROS 225
MGA, a suppressor of MYC, is recurrently inactivated in high risk chronic lymphocytic leukemia 199
IGHD3-3 fails to behave as unfavourable prognostic marker in chronic lymphocytic leukaemia. 198
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 178
Vorinostat interferes with Wnt and NF-kappaB pathways in the M-07e cell line. 169
Casein kinase 1: A new tale of chronic lymphocytic leukemia (CLL) microenvironment 169
Performance trade-offs of different rake receivers 159
Feasibility of autologous peripheral blood stem cell mobilization and harvest in adult patients with FLT3-mutated acute myeloid leukemia receiving chemotherapy combined with midostaurin: a single-center experience 152
NOX-A12: Mobilizing CLL away from home 141
Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study 120
The dynamic functions of IRF4 in B cell malignancies 105
Optical genome mapping reveals multiple apoptotic and cell-cycle pathway aberrations in B-cell prolymphocytic leukemia: a report of three cases 26
GENOMIC SCREENING OF PRIMARY REFRACTORY ACUTE MYELOID LEUKEMIA WITHOUT TP53 ALTERATIONS BY OPTICAL GENOME MAPPING (OGM) 13
OPTICAL GENOME MAPPING IDENTIFIES MULTIPLE STRUCTURAL VARIATION AND CATASTROPHIC REARRANGEMENTS IN B-CELL PROLYMPHOCYTIC LEUKEMIA 12
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia 10
XPO1 mutations identify early-stage CLL characterized by shorter time to first treatment and enhanced BCR signalling 7
Totale 16.179
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.113
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021106 0 0 0 0 0 0 0 0 0 0 0 106
2021/20221.057 64 134 93 46 29 82 53 53 97 84 215 107
2022/20231.247 128 156 103 114 168 164 15 145 134 12 53 55
2023/2024800 28 36 51 85 149 68 86 110 15 24 63 85
2024/20252.728 82 49 29 194 409 354 180 135 610 129 217 340
2025/20265.531 337 703 324 594 871 326 613 219 464 451 323 306
Totale 16.179